LBA53 ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib

Z. Piotrowska, M-J. Ahn, Y.K. Pang, S.H. How, S-W. Kim, P.J. Voon, D.L. Cortinovis, J. De Castro Carpeño, M. Tiseo, D. Rodriguez Abreu, S.S. Ramalingam, J. Li, L. Servidio, S. Sadow, R.J. Hartmaier, B.C. Cho